SCHEMBL8308314

SCHEMBL8308314

O/N=C/c1ccc(-c2ccccc2)nc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.47
CYP11B1 P15538 6/20 0.42
CYP11B2 P19099 6/20 0.42
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
BAZ2B Q9UIF8 1/20 0.41
HPGDS O60760 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
KMT2A Q03164 1/20 0.39
HPGD P15428 1/20 0.39
GFER P55789 1/20 0.39
POLB P06746 1/20 0.38
ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8308316 1.00 LDHA (0.47) LDHACYP11B1CYP11B2RAB9ANPC1
SCHEMBL8304980 0.77 TAAR1 (0.44) LDHACYP11B1CYP11B2KDM4EALDH1A1
SCHEMBL8304977 0.77 TAAR1 (0.44) LDHACYP11B1CYP11B2KDM4EALDH1A1
SCHEMBL30382878 0.76 LDHA (0.52) LDHACYP11B1CYP11B2ALDH1A1BAZ2B
SCHEMBL10160338 0.76 POLB (0.48) LDHACYP11B1CYP11B2ALDH1A1BAZ2B
SCHEMBL24518138 0.76 LDHA (0.47) LDHACYP11B1CYP11B2BAZ2BHPGDS
SCHEMBL2718039 0.76 LDHA (0.52) LDHACYP11B1CYP11B2ALDH1A1BAZ2B
SCHEMBL13112151 0.76 CYP11B1 (0.48) LDHACYP11B1CYP11B2KDM4EALDH1A1
SCHEMBL2718395 0.76 BAZ2B (0.49) LDHACYP11B1CYP11B2BAZ2BHPGDS
SCHEMBL506255 0.75 CA12 (0.52) RAB9ANPC1KDM4EALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed